These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15117386)

  • 1. Agreement between prostate cancer patients and their clinicians about utilities and attribute importance.
    Elstein AS; Chapman GB; Chmiel JS; Knight SJ; Chan C; Nadler RB; Kuzel TM; Siston AK; Bennett CL
    Health Expect; 2004 Jun; 7(2):115-25. PubMed ID: 15117386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' values and clinical substituted judgments: the case of localized prostate cancer.
    Elstein AS; Chapman GB; Knight SJ
    Health Psychol; 2005 Jul; 24(4S):S85-92. PubMed ID: 16045424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient preferences in prostate cancer: a clinician's guide to understanding health utilities.
    Kramer KM; Bennett CL; Pickard AS; Lyons EA; Wolf MS; McKoy JM; Knight SJ
    Clin Prostate Cancer; 2005 Jun; 4(1):15-23. PubMed ID: 15992457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of time trade-off utilities for health states associated with the treatment of prostate cancer.
    Saigal CS; Gornbein J; Reid K; Litwin MS
    Qual Life Res; 2002 Aug; 11(5):405-14. PubMed ID: 12113388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-attribute model of prostate cancer patient's preferences for health states.
    Chapman GB; Elstein AS; Kuzel TM; Nadler RB; Sharifi R; Bennett CL
    Qual Life Res; 1999 May; 8(3):171-80. PubMed ID: 10472149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.
    Knight SJ; Nathan DP; Siston AK; Kattan MW; Elstein AS; Collela KM; Wolf MS; Slimack NS; Bennett CL; Golub RM
    Clin Prostate Cancer; 2002 Sep; 1(2):105-14. PubMed ID: 15046701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians.
    Bennett CL; Chapman G; Elstein AS; Knight SJ; Nadler RB; Sharifi R; Kuzel T
    Eur Urol; 1997; 32 Suppl 3():86-8. PubMed ID: 9267792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent class cluster analysis to understand heterogeneity in prostate cancer treatment utilities.
    Meghani SH; Lee CS; Hanlon AL; Bruner DW
    BMC Med Inform Decis Mak; 2009 Nov; 9():47. PubMed ID: 19941668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of forecasted assessment of quality of life to validate time-trade-off utilities and a prostate cancer screening decision-analytic model.
    Cantor SB; Deshmukh AA; Krahn MD; Volk RJ
    Health Expect; 2015 Oct; 18(5):1610-20. PubMed ID: 26039695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared decision making: prostate cancer patients' appraisal of treatment alternatives and oncologists' eliciting and responding behavior, an explorative study.
    Pieterse AH; Henselmans I; de Haes HC; Koning CC; Geijsen ED; Smets EM
    Patient Educ Couns; 2011 Dec; 85(3):e251-9. PubMed ID: 21658883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS).
    Tomlinson G; Bremner KE; Ritvo P; Naglie G; Krahn MD
    Med Decis Making; 2012; 32(1):11-30. PubMed ID: 21653804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilities for prostate cancer health states in men aged 60 and older.
    Stewart ST; Lenert L; Bhatnagar V; Kaplan RM
    Med Care; 2005 Apr; 43(4):347-55. PubMed ID: 15778638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans.
    Knight SJ; Siston AK; Chmiel JS; Slimack N; Elstein AS; Chapman GB; Nadler RB; Bennett CL
    Clin Prostate Cancer; 2004 Jun; 3(1):31-7. PubMed ID: 15279688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.
    Krahn M; Ritvo P; Irvine J; Tomlinson G; Bremner KE; Bezjak A; Trachtenberg J; Naglie G
    Med Care; 2003 Jan; 41(1):153-64. PubMed ID: 12544552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting utility ratings for joint health States from single health States in prostate cancer: empirical testing of 3 alternative theories.
    Dale W; Basu A; Elstein A; Meltzer D
    Med Decis Making; 2008; 28(1):102-12. PubMed ID: 18057188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
    Jeong CW; Cowan JE; Broering JM; Ten Ham RMT; Wilson LS; Carroll PR; Cooperberg MR
    Eur Urol; 2019 Dec; 76(6):743-751. PubMed ID: 31345635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' preferences for delaying metastatic castration-resistant prostate cancer: Combining health state and treatment valuation.
    Rentz AM; Mansukhani SG; Liu J; Lloyd AJ; Heidenreich S; Matza LS; Dawson NA; Shore N; Freedland SJ
    Urol Oncol; 2021 Jun; 39(6):367.e7-367.e17. PubMed ID: 33736976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.
    Kim SP; Knight SJ; Tomori C; Colella KM; Schoor RA; Shih L; Kuzel TM; Nadler RB; Bennett CL
    Cancer Invest; 2001; 19(7):684-91. PubMed ID: 11577809
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.